Skip to main content

Orthopedic Medical Imaging Market continues to grow with GE Healthcare receiving the U.S. FDA clearance for its OEC 3D, a new surgical imaging system capable of 3D and 2D

 


Orthopedic medical imaging has many uses in modern medicine. Some of these include mammography, ultrasound, magnetic resonance imaging (MRI), and tomography. These different types of technology are used in order to help doctors see and treat problems more clearly. Orthopedic medical imaging has become incredibly useful for the diagnosis of various orthopedic diseases. These diseases include arthritis, osteoporosis, Carpal Tunnel Syndrome, ligament injuries, etc. As per the Centers for Disease Control and Prevention (CDC), by 2040, around 78 million U.S. adults aged 18 years and above are estimated to have doctor-diagnosed arthritis. Similarly, as per Beaumont Health, around 100,000 to 200,000 anterior cruciate ligament (ACL) cases occur each year in the U.S. Such injuries and bone-related diseases require accurate diagnosis, for which medical imagining becomes the primary solution. Thus, such factors can augment growth of the orthopedic medical imagining market.

Developed countries such as the U.S. and Canada have robust healthcare infrastructure. Besides, there is a high incidence of orthopedic disorders, which can potentially accelerate the regional growth of the orthopedic medical imaging market. On the contrary, emerging economies in the Asia Pacific are exhibiting positive signs in terms of the adoption of orthopedic medical imaging. This is due to rising expenditure on healthcare facilities and growing geriatric population.

Recently, in March 2021, GE Healthcare received the U.S. Food and Drug Administration (FDA) 510(k) clearance for its OEC 3D, a new surgical imaging system capable of 3D and 2D imaging. 

Orthopedic equipment comes in many different sizes and shapes. It should be strongly considered before buying any particular item. Some of the most popular brands include MRI gear, Tomography equipment, and ultrasound machines. All of these items are very useful for many different kinds of purposes. Finding the right orthopedic equipment is important. However, there are certain challenges associated with the adoption of these imaging solutions with high expenses in clinical trials being one of them. Besides, stringent regulatory restrictions and growing burden on healthcare budgets in the U.S. can impede growth of the orthopedic medical imaging market in the near future.

Magnetic resonance imaging (MRI) is often used to get information about the brain. This method works by creating a very strong magnetic field that is used to map out parts of the brain. Many times this is done in a lab. The elderly population is highly vulnerable to orthopedic diseases. With the rapidly growing geriatric population, the incidence of subsequent orthopedic diseases is likely to grow in the near future. As per the World Health Organization (WHO), the geriatric population is likely to reach 2 billion by 2050, increasing from 900 million in 2015. Such factors can stimulate growth of the orthopedic medical imaging market.

 

    

 

Comments

Popular posts from this blog

Life Sciences BPO Market is Expected to Grow Drastically, Assured By Experts From 2023 To 2028

  The growing cost of drug development is augmenting the growth of the global life sciences BPO market. For instance, according to a study by the Tufts Center for the Study of Drug Development published in the Journal of Health Economics in May 2019, the cost of drug development was US$ 2.6 billion, which included average out-of-pocket costs of US$ 1.4 billion and time costs of US$ 1.2 billion. Also, patent expiration is another key factor propelling the growth of the life sciences BPO market. For instance, the patent for YAZ (drospirenone/ethinylestradiol), which provides an oral contraceptive regimen, is set to expire in 2021. Furthermore, the rising prevalence of chronic disease around the globe is further anticipated to accelerate the growth of the market. North America is projected to lead the global life sciences BPO market due to increasing R&D in cell therapies by key players in the region. For instance, in February 2020, Caribou Biosciences, Inc., a CRISPR genome editin

Increasing various research activities is propelling growth of the pediatric vaccines market

  Pediatric Vaccine Market: Global Trends Over the course of the forecast period, rising public awareness of vaccinations and immunisation is anticipated to fuel market expansion for paediatric vaccines worldwide. For instance, the United States recognises January as Cervical Health Awareness Month, promoting the value of routine immunisation and screening in the fight against cancer. Global Pediatric Vaccine Market: Drivers Increasing awareness regarding vaccines and immunization among the populace is expected to boost growth of the global pediatric vaccine market over the forecast period. For instance, in the U.S., the month of January is celebrated as Cervical Health Awareness Month, wherein the importance of regular vaccination and screening in the prevention of cancer is forwarded.

Epidermolysis Bullosa Therapeutics Market Is Booming Worldwide 2023-2028

  Epidermolysis bullosa is a group of rare inherited skin disorders that causes the skin to become very fragile. Any trauma or friction to the skin can cause painful blisters. The symptoms of epidermolysis bullosa include skin that blisters easily, blisters on hands and soles of the feet, thickened skin that may be scarred or change color over time, and thickening of the skin and nails. There are three types of epidermolysis bullosa which includes: ·          Epidermolysis bullosa simplex (EBS) – the most common type, which can range from mild, with a low risk of serious complications to severe ·          Dystrophic epidermolysis bullosa (DEB) – which can range from mild to severe ·          Junctional epidermolysis bullosa (JEB) – a rare form of epidermolysis bullosa that ranges from moderate to severe The type reflects where on the body the blistering takes place and which layer of skin is affected. Global epidermolysis bullosa market is estimated to be valued at  US$ 3,